Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 10.66
-0.35 (-3.18%)
Nov 13, 2026, 3:04 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 4.45 billion as of November 12, 2026. It is the 12,373rd most valuable company in the world and the 3,116th biggest in China. Its market cap has decreased by 31.23% in one year.
Market Cap
4.45B
Enterprise Value
2.94B
Revenue
488.84M
Global Rank
Country Rank
#3,116 China
PE Ratio
90.01
ChartMarket Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 4.45B, a decrease of -50.30%. That is a compound annual growth rate of -13.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.45B | -12.77% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding